Annual SG&A
$20.39 M
-$2.49 M-10.89%
31 December 2023
Summary:
Humacyte annual selling, general & administrative expenses is currently $20.39 million, with the most recent change of -$2.49 million (-10.89%) on 31 December 2023. During the last 3 years, it has risen by +$8.38 million (+69.73%). HUMA annual SG&A is now -10.89% below its all-time high of $22.88 million, reached on 31 December 2022.HUMA Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$7.31 M
+$1.56 M+27.17%
30 September 2024
Summary:
Humacyte quarterly selling, general & administrative expenses is currently $7.31 million, with the most recent change of +$1.56 million (+27.17%) on 30 September 2024. Over the past year, it has increased by +$1.24 million (+20.38%). HUMA quarterly SG&A is now at all-time high.HUMA Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$2.40 B
-$152.87 M-6.81%
30 September 2024
Summary:
Humacyte TTM selling, general & administrative expenses is currently -$2.40 billion, with the most recent change of -$152.87 million (-6.81%) on 30 September 2024. Over the past year, it has dropped by -$2.42 billion (-11956.35%). HUMA TTM SG&A is now -517.75% below its all-time high of $24.37 million, reached on 30 September 2024.HUMA TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HUMA Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.9% | +20.4% | -10000.0% |
| 3 y3 years | +69.7% | +35.4% | -10000.0% |
| 5 y5 years | - | - | - |
HUMA Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -10.9% | +69.7% | at high | +136.9% | -183.6% | at low |
| 5 y | 5 years | -10.9% | +69.7% | at high | +181.4% | -517.8% | at low |
| alltime | all time | -10.9% | +69.7% | at high | +181.4% | -517.8% | at low |
Humacyte Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.31 M(+27.2%) | $24.37 M(+5.3%) |
| June 2024 | - | $5.75 M(+8.1%) | $23.13 M(+13.0%) |
| Mar 2024 | - | $5.31 M(-11.5%) | $20.47 M(+0.4%) |
| Dec 2023 | $20.39 M(-10.9%) | $6.00 M(-1.1%) | $20.39 M(+0.8%) |
| Sept 2023 | - | $6.07 M(+96.8%) | $20.22 M(-0.6%) |
| June 2023 | - | $3.08 M(-41.1%) | $20.34 M(-9.3%) |
| Mar 2023 | - | $5.23 M(-10.3%) | $22.43 M(-2.0%) |
| Dec 2022 | $22.88 M | $5.83 M(-5.7%) | $22.88 M(+1.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $6.19 M(+19.5%) | $22.60 M(+3.6%) |
| June 2022 | - | $5.18 M(-8.8%) | $21.81 M(-1.0%) |
| Mar 2022 | - | $5.68 M(+2.3%) | $22.02 M(+4.2%) |
| Dec 2021 | $21.13 M(+75.9%) | $5.55 M(+2.9%) | $21.13 M(+16.3%) |
| Sept 2021 | - | $5.40 M(+0.1%) | $18.17 M(+12.1%) |
| June 2021 | - | $5.39 M(+12.6%) | $16.21 M(+49.8%) |
| Mar 2021 | - | $4.79 M(+84.3%) | $10.82 M(+79.4%) |
| Dec 2020 | $12.01 M | $2.60 M(-24.4%) | $6.03 M(+75.6%) |
| Sept 2020 | - | $3.44 M | $3.44 M |
FAQ
- What is Humacyte annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Humacyte?
- What is Humacyte annual SG&A year-on-year change?
- What is Humacyte quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Humacyte?
- What is Humacyte quarterly SG&A year-on-year change?
- What is Humacyte TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Humacyte?
- What is Humacyte TTM SG&A year-on-year change?
What is Humacyte annual selling, general & administrative expenses?
The current annual SG&A of HUMA is $20.39 M
What is the all time high annual SG&A for Humacyte?
Humacyte all-time high annual selling, general & administrative expenses is $22.88 M
What is Humacyte annual SG&A year-on-year change?
Over the past year, HUMA annual selling, general & administrative expenses has changed by -$2.49 M (-10.89%)
What is Humacyte quarterly selling, general & administrative expenses?
The current quarterly SG&A of HUMA is $7.31 M
What is the all time high quarterly SG&A for Humacyte?
Humacyte all-time high quarterly selling, general & administrative expenses is $7.31 M
What is Humacyte quarterly SG&A year-on-year change?
Over the past year, HUMA quarterly selling, general & administrative expenses has changed by +$1.24 M (+20.38%)
What is Humacyte TTM selling, general & administrative expenses?
The current TTM SG&A of HUMA is -$2.40 B
What is the all time high TTM SG&A for Humacyte?
Humacyte all-time high TTM selling, general & administrative expenses is $24.37 M
What is Humacyte TTM SG&A year-on-year change?
Over the past year, HUMA TTM selling, general & administrative expenses has changed by -$2.42 B (-11956.35%)